MiR-145-5p inhibits the EGFR/RAF/MEK/ERK pathway by targeting rhomboid domain containing protein 1 (RHBDD1) and its downregulation in CRC is associated with poor prognosis [59]. Here, RAF1 is linked to colorectal carcinoma.